Dr Dee Domingo

Research Associate

Centre for Cancer Biology

College of Health


Dr Dee Domingo is a Postdoctoral Researcher in the Neurovascular Research Laboratory (Neural Crest and Cardiac Development Group) at the Centre for Cancer Biology. Her research investigates the cellular and molecular mechanisms by which Neural Crest Cells influence the developing heart, with a particular interest in how disruption to these processes drives Congenital Heart Defects including Pulmonary Stenosis.
 
Neural Crest Cells play a critical role in guiding the remodelling of the pharyngeal arch arteries – a series of embryonic blood vessels that give rise to the great vessels of the heart, including the aorta and pulmonary artery. Dr Domingo’s work centres on how Neural Crest Cell-Specific Notch signalling uniquely drives the remodelling of the 6th pharyngeal arch artery (remodels into the pulmonary artery) and the pulmonary valves.
 
Using conditional knockout mouse models, she examines how loss of Notch signalling in Neural Crest Cells produces clinically relevant stenotic phenotypes, smooth muscle loss and dysregulated cell signalling and differentiation. Dr Domingo’s Research is underpinned by a suite of advanced imaging and molecular techniques, including whole embryo light sheet fluorescence microscopy, 3D vascular modelling, fetal echocardiography, immunofluorescence and immunohistochemistry.

Date Position Institution name
2024 - ongoing Postdoctoral Researcher Adelaide University
2021 - 2024 Cellar Door Manager & Sales Primo Estate Wines
2021 - 2024 Owner Dee's Coffee Van
2020 - 2021 Researcher Flinders University
2009 - 2020 Pharmacy Assistant Terry White Chemist

Date Institution name Country Title
2016 - 2020 The University of Adelaide Australia PhD (Neurogenetics/Molecular Biolgy)
2012 - 2014 The University of Adelaide Australia Bachelor of Science (Molecular Biology)

Year Citation
2026 Wiszniak, S., Alankarage, D., Lohraseb, I., Marchant, C., Secker, G., Domingo, D., . . . Schwarz, Q. (2026). Neural crest cell-derived DKK1 and NEDD4 modulate Wnt signalling in the second heart field to orchestrate outflow tract development.. Nature Communications, 17(1), 17511-1751-17.
DOI
2023 Mui, B., Leong, N., Keil, B., Domingo, D., Dafny, H. A., Manchaiah, V., . . . Shekhawat, G. S. (2023). COVID-19 and tinnitus: an initiative to improve tinnitus care. International Journal of Audiology, 62(9), 826-834.
DOI Scopus9 WoS8 Europe PMC5
2022 Tang, D., Tran, Y., Lewis, J. R., Bondonno, N. P., Bondonno, C. P., Hodgson, J. M., . . . Gopinath, B. (2022). Associations between intake of dietary flavonoids and the 10-year incidence of tinnitus in older adults. European Journal of Nutrition, 61(4), 1957-1964.
DOI Scopus9 Europe PMC8
2022 Kok, T. E., Domingo, D., Hassan, J., Vuong, A., Hordacre, B., Clark, C., . . . Shekhawat, G. S. (2022). Resting-state networks in tinnitus: a scoping review. Clinical Neuroradiology, 32(4), 903-922.
DOI Scopus25 WoS25 Europe PMC23
2020 Johnson, B. V., Gecz, J., Jolly, L., Sharma, R., Corbett, M., Perez-Jurado, L., . . . Domingo, D. (2020). Partial loss of USP9X function leads to a male neurodevelopmental and behavioural disorder converging on TGFβ signalling. Biological Psychiatry, 87(2), 100-112.
DOI Scopus59 WoS57 Europe PMC52
2020 Domingo, D., Nawaz, U., Corbett, M., Espinoza, J. L., Tatton-Brown, K., Coman, D., . . . Jolly, L. A. (2020). A synonymous UPF3B variant causing a speech disorder implicates NMD as a regulator of neurodevelopmental disorder gene networks. Human Molecular Genetics, 29(15), 2568-2578.
DOI Scopus17 WoS17 Europe PMC15
2019 Johnson, J. L., Stoica, L., Liu, Y., Zhu, P. J., Bhattacharya, A., Buffington, S., . . . Costa-Mattioli, M. (2019). Inhibition of Upf2-dependent nonsense-mediated decay leads to behavioral and neurophysiological abnormalities by activating the immune response. Neuron, 104(4), 665-679.e8.
DOI Scopus58 WoS57 Europe PMC59
2018 Cheng, H., Dharmadhikari, A., Varland, S., Ma, N., Domingo, D., Kleyner, R., . . . Lyon, G. (2018). Truncating variants in NAA15 are associated with variable levels of intellectual disability, autism spectrum disorder, and congenital anomalies. American Journal of Human Genetics, 102(5), 985-994.
DOI Scopus68 WoS64 Europe PMC75
2017 Bridges, C., Tan, M., Premarathne, S., Nanayakkara, D., Bellette, B., Zencak, D., . . . Wood, S. (2017). USP9X deubiquitylating enzyme maintains RAPTOR protein levels, mTORC1 signalling and proliferation in neural progenitors. Scientific Reports, 7(1), 391-1-391-15.
DOI Scopus38 WoS37 Europe PMC37
2016 Reijnders, M., Zachariadis, V., Latour, B., Jolly, L., Mancini, G., Pfundt, R., . . . Kleefstra, T. (2016). De novo loss-of-function mutations in USP9X cause a female-specific recognizable syndrome with developmental delay and congenital malformations. American Journal of Human Genetics, 98(2), 373-381.
DOI Scopus101 WoS92 Europe PMC83
2015 Jolly, L., Nguyen, L., Domingo, D., Sun, Y., Barry, S., Hancarova, M., . . . Gecz, J. (2015). HCFC1 loss-of-function mutations disrupt neuronal and neural progenitor cells of the developing brain.. Human Molecular Genetics, 24(12), 3335-3347.
DOI Scopus45 WoS46 Europe PMC53

Date Role Committee Institution Country
2026 - ongoing Member ANZSCDB SA 2026 Australia and New Zealand Society for Cell and Developmental Biology Australia

Connect With Me

External Profiles

Other Links